CIK: 1366268 - Address: C/O Inhibrx Biosciences, Inc., 11025 North Torrey Pines Road, Suite 140, La Jolla, CA 92037
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/22/24 16:03
11/19/24
INBXInhibrx Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagKayyem Jon FaizCADP.m1,52414.210107330140I
6/7/24 18:05
6/5/24
INBXInhibrx Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagKayyem Jon FaizCADP99717.3205851,150I
6/4/24 17:27
5/31/24
INBXInhibrx Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagKayyem Jon FaizCADP.m4,92817.180287361,093I
4/4/23 16:36
3/31/23
BDSXBiodesix IncDEHealthHealthMedical LaboratoriesKayyem Jon FaizCODM.d00.00014671351D
1/23/23 18:10
1/23/23
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagKayyem Jon FaizCADS-24025.260-1003,274I
12/22/22 16:31
12/21/22
BDSXBiodesix IncDEHealthHealthMedical LaboratoriesKayyem Jon FaizCODM.d00.0003218206D
12/22/22 16:04
12/21/22
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagKayyem Jon FaizCADS-25727.020-1003,284I
11/22/22 16:42
11/21/22
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagKayyem Jon FaizCADS-28429.890-1003,293I
11/21/22 18:02
11/21/22
BDSXBiodesix IncDEHealthHealthMedical LaboratoriesKayyem Jon FaizCODP2001.150174New174I
10/24/22 16:36
10/21/22
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagKayyem Jon FaizCADS-28630.130-1003,303I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact